Education
About Us
Working with TipRanks
Follow Us
Getinge (GB:0GZV)
LSE:0GZV
0GZV Stock Chart & Stats
kr215.37
kr0.56(0.30%)
At close: 4:00 PM EST
kr215.37
kr0.56(0.30%)
Day’s Range― - ―
52-Week Rangekr177.75 - kr230.10
Previous CloseN/A
Volume17.36K
Average Volume (3M)108.58K
Market Cap
kr54.13B
Enterprise Valuekr63.01B
Total Cash (Recent Filing)kr3.40B
Total Debt (Recent Filing)kr11.91B
Price to Earnings (P/E)24.1
Beta0.69
Next Earnings
Apr 21, 2026EPS Estimate
1.78Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.45
Shares Outstanding254,152,370
10 Day Avg. Volume166,450
30 Day Avg. Volume108,580
Financial Highlights & Ratios
PEG Ratio0.70
Price to Book (P/B)2.03
Price to Sales (P/S)1.70
P/FCF Ratio22.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr235.00Price Target Upside9.11% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring Revenue & Service ContractsGetinge's mix of direct product sales plus ongoing maintenance, service contracts and consumables builds recurring revenue. That recurring income increases customer stickiness, stabilizes cash flows and supports durable margin and investment planning over the next 2–6 months.
Broad, Diversified Product PortfolioExposure across Surgical Workflows, Critical Care and Life Science provides structural diversification and cross‑sell opportunities. Serving hospitals and biopharma reduces single‑market cyclicality and lets R&D investments leverage multiple end markets for sustained revenue resilience.
Positive Operating Cash GenerationConsistent operating cash flow and historically strong free cash flow (notably 2024) give Getinge the ability to fund R&D, service debt and support capex or dividends. Solid cash generation underpins financial flexibility through typical industry cycles.
Bears Say
Flat And Uneven Revenue TrendStagnant top‑line growth limits scale benefits and reduces potential for operating‑leverage gains. Over the medium term, flat revenues constrain reinvestment capacity, weaken competitive positioning versus faster‑growing peers and raise execution risk for long‑term targets.
Margin Compression And Volatile ProfitabilitySustained margin pressure and swings in net income suggest weaker pricing power or rising costs and inconsistent operational execution. This undermines earnings quality and makes free cash flow and returns on invested capital less predictable over the coming quarters.
Rising Debt Trend And Reduced Equity In 2025An increasing debt burden alongside lower equity reduces financial flexibility and raises leverage risk. Higher indebtedness can increase interest costs and constrain strategic choices (M&A, R&D, pricing support), leaving the company more exposed to demand or margin shocks.
Getinge News
0GZV FAQ
What was Getinge’s price range in the past 12 months?
Getinge lowest share price was kr177.75 and its highest was kr230.10 in the past 12 months.
What is Getinge’s market cap?
Getinge’s market cap is kr54.13B.
When is Getinge’s upcoming earnings report date?
Getinge’s upcoming earnings report date is Apr 21, 2026 which is in 54 days.
How were Getinge’s earnings last quarter?
Getinge released its earnings results on Jan 27, 2026. The company reported kr4.45 earnings per share for the quarter, beating the consensus estimate of kr4.084 by kr0.366.
Is Getinge overvalued?
According to Wall Street analysts Getinge’s price is currently Undervalued.
Does Getinge pay dividends?
Getinge does not currently pay dividends.
What is Getinge’s EPS estimate?
Getinge’s EPS estimate is 1.78.
How many shares outstanding does Getinge have?
Getinge has 254,152,370 shares outstanding.
What happened to Getinge’s price movement after its last earnings report?
Getinge reported an EPS of kr4.45 in its last earnings report, beating expectations of kr4.084. Following the earnings report the stock price went down -5.558%.
Which hedge fund is a major shareholder of Getinge?
Currently, no hedge funds are holding shares in GB:0GZV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Getinge
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, logistic automation solutions, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; practice-oriented monitoring systems and disposables, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected solutions, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products. The company also provides thoracic catheters, dry seal chest drain, mobile dry seal drain, dry and wet suction water seal chest drain, and chest drain valves; transitional accessories; endoscope reprocessing; endoscopic vessel harvesting systems; endovascular products; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packing products; intra-aortic balloon counter pulsation therapies; mechanical ventilation products; medical furniture; modular room systems; operating lights and tables; OR integration and management; patient flow management; patient transport; sterile supply management; sterilization; surgical assist systems; surgical perfusion; transport & storage; trays & baskets; and vascular and cardiothoracic surgery solutions. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
0GZV Stock 12 Month Forecast
Average Price Target
kr235.00
▲(9.11% Upside)
Technical Analysis
Vitrolife AB
―
CellaVision AB
―
Xvivo Perfusion AB
―
Sectra AB Class B
―
Sedana Medical AB
―
Options Prices
Currently, No data available
---